Target
Transcription initiation factor TFIID subunit 1 [1381-1497]
Ligand
BDBM346445
Substrate
n/a
Meas. Tech.
TAF1-BD1 TR-FRET Binding Assay
IC50
315±n/a nM
Citation
 Adler, MBurdick, DJCrawford, TDuplessis, MMagnuson, SRNasveschuk, CGRomero, FATang, YTsui, VHWang, S Therapeutic compounds and uses thereof US Patent  US10202378 Publication Date 2/12/2019
Target
Name:
Transcription initiation factor TFIID subunit 1 [1381-1497]
Synonyms:
BA2R | CCG1 | CCGS | TAF1 | TAF1-BD1 | TAF1-BD1 (aa 1381-1497) | TAF1_HUMAN | TAF2A
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25344.81
Organism:
Homo sapiens (human)
Description:
P21675[1381-1497]
Residue:
217
Sequence:
PMVTLSSILESIINDMRDLPNTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYPSREEFREHLELIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLDDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIV
  
Inhibitor
Name:
BDBM346445
Synonyms:
US10202378, Example 58 | ethyl 4-[2-(4-methoxyphenyl)ethynyl]-2,6-dimethyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-3-carboxylate
Type:
Small organic molecule
Emp. Form.:
C21H20N2O4
Mol. Mass.:
364.3945
SMILES:
CCOC(=O)c1c(C)[nH]c2c1c(cn(C)c2=O)C#Cc1ccc(OC)cc1
Structure:
Search PDB for entries with ligand similarity: